Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1166496

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1166496

Glutathione Market Size- By Type, By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Global Glutathione Market Overview:

According to SPER Market Research, the Global Glutathione Market is estimated to reach USD 1.03 billion by 2032 with a CAGR of 8.8%.

A tripeptide substance called glutathione is created from the amino acid glycine, cysteine, and glutamic acid. Important cellular components of the human body are susceptible to damage from reactive oxygen species, including free radicals, peroxides, lipid peroxides, and heavy metals. Glutathione aids in avoiding this damage. An essential antioxidant in the human body, glutathione helps fight free radicals, detoxify substances produced naturally by the body, as well as pharmaceuticals and environmental contaminants. Additionally, glutathione is used to treat impaired immune systems, infertility, and cancer's damaging side effects from radiation and chemotherapy. These advantages of the product ought to increase glutathione's market share in the global pharmaceutical and food sectors.

Impact of COVID-19 on the Global Glutathione Market

The COVID-19 epidemic has altered customers' purchasing behaviour. Panic purchases of food and sanitary supplies have resulted from measures like the countrywide lockdown. A growing number of patients are preferring self-medication over doctor visits in the wake of the COVID-19 issue. As a result, many people have stocked up on over-the-counter medications for symptom alleviation. The demand for goods that aid in strengthening immunity has also grown as a result of greater consumer knowledge of and interest in the significance of preventative health. The need for health supplements has increased as a result. During the pandemic, the market for glutathione is anticipated to rise because to the general increase in demand for medications.

Scope of the Report:

Report Metric Details

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Type, By Product, By Application
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: Bio-Rad Laboratories Inc., Cytiva, Jarrow Formulas Inc., Kaiping Genuine Biochemical Pharmaceutical Co. Ltd., Kohjin Life Sciences Co. Ltd., Kyowa Hakko Bio Co. Ltd., Merck KGaA, Mitsubishi Corporation Life Sciences Ltd., Nissor Pharmaceuticals Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., Shenzhen GSH Bio-Technology Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc.

Global Glutathione Market Segmentation:

  • By Type: Based on the Type, Global Glutathione Market is segmented as; L-Glutathione, Acetyl-Glutathione.
  • By Product: Based on the Product, Global Glutathione Market is segmented as; Oxidized Glutathione, Reduced Glutathione.
  • By Application: Based on the Application, Global Glutathione Market is segmented as; Food & Beverages, Immunoprecipitation, Personal Care & Cosmetics, Pharmaceuticals, Protein Purification, Research, Others.
  • By Region: Over the projected period, Asia Pacific is expected to develop at the quickest CAGR of any major region, accounting for the greatest revenue share of all other regions. This share is attributable to the expanding government support for domestic manufacturing, which is predicted to increase output levels and lessen reliance on imports in the Asia Pacific area, providing profitable prospects for international manufacturers. Over the projected period, the market is also anticipated to be driven by the expanding pharmaceutical R&D industry. In terms of volume, North America is the largest market, and it is anticipated that it would expand at a significant CAGR over the forecast period. The development of vaccines to treat illnesses like the present Coronavirus pandemic and the increased need for biochemical research applications are two key reasons driving the regional industry. Demand for the product is anticipated to increase in North America due to the growing use of purified proteins and antibodies in medicinal applications.
Product Code: CHEM2208

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Glutathione Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Glutathione Market, By Type, 2019-2032 (USD Million)

  • 6.1. L-Glutathione
  • 6.2. Acetyl-Glutathione

7. Global Glutathione Market, By Product, 2019-2032 (USD Million)

  • 7.1. Oxidized Glutathione
  • 7.2. Reduced Glutathione

8. Global Glutathione Market, By Application, 2019-2032 (USD Million)

  • 8.1. Food & Beverages
  • 8.2. Immunoprecipitation (IP)
  • 8.3. Personal Care & Cosmetics
  • 8.4. Pharmaceuticals
  • 8.5. Protein Purification
  • 8.6. Research
  • 8.7. Others

9. Global Glutathione Market, By Region, 2019-2032 (USD Million)

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 United Kingdom
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 Australia
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Rest of South America
  • 9.5 Middle East & Africa
    • 9.5.1 Kingdom of Saudi Arabia
    • 9.5.2 United Arab Emirates
    • 9.5.3 Rest of Middle East & Africa

10. Company Profiles

  • 10.1 Bio-Rad Laboratories Inc.
    • 10.1.1 Company details
    • 10.1.2 Financial outlook
    • 10.1.3 Product summary
    • 10.1.4 Recent developments
  • 10.2 Cytiva
    • 10.2.1 Company details
    • 10.2.2 Financial outlook
    • 10.2.3 Product summary
    • 10.2.4 Recent developments
  • 10.3 Jarrow Formulas Inc.
    • 10.3.1 Company details
    • 10.3.2 Financial outlook
    • 10.3.3 Product summary
    • 10.3.4 Recent developments
  • 10.4 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
    • 10.4.1 Company details
    • 10.4.2 Financial outlook
    • 10.4.3 Product summary
    • 10.4.4 Recent developments
  • 10.5 Kohjin Life Sciences Co. Ltd.
    • 10.5.1 Company details
    • 10.5.2 Financial outlook
    • 10.5.3 Product summary
    • 10.5.4 Recent developments
  • 10.6 Kyowa Hakko Bio Co. Ltd.
    • 10.6.1 Company details
    • 10.6.2 Financial outlook
    • 10.6.3 Product summary
    • 10.6.4 Recent developments
  • 10.7 Merck KGaA
    • 10.7.1 Company details
    • 10.7.2 Financial outlook
    • 10.7.3 Product summary
    • 10.7.4 Recent developments
  • 10.8 Mitsubishi Corporation Life Sciences Ltd.
    • 10.8.1 Company details
    • 10.8.2 Financial outlook
    • 10.8.3 Product summary
    • 10.8.4 Recent developments
  • 10.9 Nissor Pharmaceuticals Ltd.
    • 10.9.1 Company details
    • 10.9.2 Financial outlook
    • 10.9.3 Product summary
    • 10.9.4 Recent developments
  • 10.10 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
    • 10.10.1 Company details
    • 10.10.2 Financial outlook
    • 10.10.3 Product summary
    • 10.10.4 Recent developments
  • 10.11 Shenzhen GSH Bio-Technology Co. Ltd.
    • 10.11.1 Company details
    • 10.11.2 Financial outlook
    • 10.11.3 Product summary
    • 10.11.4 Recent developments
  • 10.12 Takara Bio Inc.
    • 10.12.1 Company details
    • 10.12.2 Financial outlook
    • 10.12.3 Product summary
    • 10.12.4 Recent developments
  • 10.13 Thermo Fisher Scientific Inc.
    • 10.13.1 Company details
    • 10.13.2 Financial outlook
    • 10.13.3 Product summary
    • 10.13.4 Recent developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!